Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies after the Big Pharma exercised…

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to…

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to…

Aviceda Therapeutics has secured $207.5 million in series C funds as the immunomodulator-focused biotech awaits a phase 3 readout this…

Candid Therapeutics is continuing its mission to flesh out a pipeline of T-cell engagers in record time, signing a $925…

In a groundbreaking interview featured in Genomic Press, Dr. Carrie E. Bearden, a distinguished Professor of Psychiatry and Biobehavioral Sciences…

AbbVie, Calico and Denali Therapeutics’ hopes of treating amyotrophic lateral sclerosis (ALS) by targeting eIF2B have all taken a hit.…

In recent years, the landscape of memory technologies has evolved significantly, driven by the insatiable demand for speed and efficiency…

CytomX Therapeutics is shrinking its head count by 40% as the biotech regroups and looks at fresh ways to conserve…

In the face of escalating climate change, the enhancement of carbon dioxide (CO2) capture technology has emerged as a pivotal…